COV-DrugX Pipeline for Covid-19 Drug Repurposing
Kamal Rawal, Prashant Raj Singh, Robin Sinha, Swarsat Kaushik Nath, P. Preeti, Priya Kumari, Sukriti Sahai, Ridhima Dahiya, Nikita Garg, Trapti Sharma · 2021
The outbreak of the novel coronavirus disease COVID-19, caused by the SARS-CoV-2 virus has killed over 5 million people to date. Despite the introduction of population-wide vaccination drives, countries such as Austria and Germany are witnessing the re-emergence of infections and deaths. Scientists, administrators and clinicians are scrambling to find solutions that include vaccines, and active therapeutic agents. So, there is an urgent requirement for new and effective medications that can treat the disease caused by SARS-CoV-2. Artificial intelligence (AI) enabled drug repurposing, has the potential to shorten the time and reduce the cost compared to de novo drug discovery.